Gilead CEO Daniel O'Day Exercises RSUs; Sells 4,213 Shares

What Happened

• Daniel Patrick O'Day, Chairman & CEO of Gilead Sciences (GILD), had 8,779 restricted stock units (RSUs) convert to common shares on June 10, 2026. To satisfy tax withholding, 4,213 of those shares were surrendered/sold at $121.48 each, generating $511,795. The conversion is reported as a derivative exercise (code M) with the withholding reported under code F.

Key Details

• Transaction date: 2026-06-10; filing date: 2026-06-11 (filed next day).
• RSUs converted: 8,779 shares (no exercise price applicable / N/A).
• Shares withheld/sold for taxes: 4,213 shares at $121.48 each = $511,795.
• Net shares received by O'Day from the vesting: 8,779 − 4,213 = 4,566 shares (shares owned after transaction not disclosed in the filing).
• Footnotes: F1 — each RSU = right to one share; F2 — RSUs follow a four‑year vesting schedule (25% at 1 year, then 6.25% quarterly).
• Transaction codes: M = exercise/conversion of derivative (RSU vesting), F = shares used to pay tax liability (withholding).

Context

• This was an RSU vesting event with routine tax withholding (a cashless share surrender), not an open‑market purchase or discretionary sale; such withholding is common and does not necessarily signal insider sentiment.